SMS Pharmaceuticals has invested an amount of Rs 6.98 crore in equity shares of VKT Pharma, an associate company, by subscribing 310,000 equity shares, face value of Rs 10 each at a price of Rs 225 per share, including premium of Rs 215 per share, which have been allotted to the company. After considering this present acquisition, the total holding of the company stood at 40.26% in the total paid-up share capital of VKT Pharma.
SMS Pharmaceuticals is a global player in API manufacturing having a strong research and manufacturing team supported by state of the art facilities.
